Cervical Cancer Screening Gaps Persist as Countries Step Up Elimination Efforts

Millions of women continue to miss opportunities for early cervical cancer detection, despite growing efforts by governments to expand screening, diagnosis and treatment services, the World Health Organization (WHO) has warned.

New WHO estimates indicate that three in five women aged 30–49 have never undergone cervical cancer screening, exposing significant gaps in access to preventive healthcare.The inequalities are particularly pronounced in access to human papillomavirus (HPV) testing, which helps identify women at risk of developing cervical cancer.

Only 2 per cent of women in low- and middle-income countries received HPV-based screening in the five years preceding the assessment, compared with 32 per cent in high-income countries.As the world marks Cervical Cancer Elimination Day on November 17, WHO is calling on governments to expand screening services, particularly for women who have historically been excluded from preventive healthcare, and ensure that those with positive results receive timely diagnosis and treatment.

WHO Director of Noncommunicable Diseases and Mental Health Søren Brostrøm said women who had missed HPV vaccination opportunities should not also be excluded from cervical cancer screening.He emphasised that available technologies can identify and treat precancerous changes before they progress into cancer, but stressed that screening must be accompanied by effective follow-up and treatment services.

Countries expand prevention programmesSeveral countries are translating cervical cancer elimination commitments into national policies and expanded healthcare services.In Brazil, HPV DNA testing has been incorporated into the public health system in 26 of the country’s 27 federal units, widening access to more effective screening methods.

Cabo Verde is preparing to introduce organised HPV-based screening on Boa Vista Island, with technical assistance from WHO and the Spanish Agency for International Development Cooperation.In El Salvador, the Ministry of Health is pursuing regional agreements, supported by the Pan American Health Organization and Unitaid, to improve access to affordable HPV screening.

New Zealand has announced a Cervical Cancer Elimination Plan covering 2026–2040, alongside plans to provide free cervical screening to all eligible women from March 2027.Meanwhile, Sierra Leone is investing in screening, diagnostic and treatment capacity, including HPV testing and equipment for identifying and managing precancerous cervical lesions, with WHO support.

These initiatives reflect growing efforts to move cervical cancer prevention beyond policy commitments and integrate screening and treatment into routine healthcare delivery.WHO strengthens technical supportTo accelerate progress, WHO has introduced additional technical guidance to help countries improve the quality and reach of cervical cancer screening programmes.

In 2026, the organisation released updated guidance on HPV DNA genotyping, providing recommendations for identifying women at higher risk of cervical precancer and determining appropriate follow-up and treatment.WHO also published practical guidance to support the introduction and expansion of HPV-based screening programmes, taking into account countries’ healthcare resources, national priorities and implementation needs.

Building the capacity of healthcare workers is another priority.Through its WHO Academy learning programme, the organisation is supporting training in cervical cancer screening, diagnosis and management of precancerous conditions.In Liberia, training materials supported the preparation of health workers from 12 health facilities in Nimba and Grand Bassa counties in July 2026.Zambia is also preparing to pilot the learning programme in December 2026 with WHO support.

The 2030 elimination targetsThis year’s World Cervical Cancer Elimination Day is being observed under the theme, “Together We Can Eliminate Cervical Cancer”, bringing together governments, healthcare workers, survivors, civil society organisations and development partners.

Activities include an HPV vaccination campaign in Benin, a health diplomacy dialogue involving Guyana and partners in Geneva, the introduction of a national elimination roadmap in Morocco and community screening initiatives in Senegal and Malaysia.T

hese efforts contribute to WHO’s global strategy, which sets three targets for 2030:90 per cent: Girls fully vaccinated against HPV by the age of 15.70 per cent: Women screened using a high-performance test by ages 35 and 45.90 per cent: Women diagnosed with cervical precancer or invasive cervical cancer receiving appropriate treatment.

While countries are expanding prevention and treatment programmes, the latest screening figures highlight the distance still to be covered, particularly in low- and middle-income settings.Achieving elimination will require more than introducing screening technologies.

Governments must also address inequalities in access, strengthen health worker capacity and ensure that women can move from screening to diagnosis and treatment without delays.

Leave a Reply

Your email address will not be published. Required fields are marked *